Astellas taps AI to reshape clinical programs as rising stars emerge
As it prepares to compete in the KRAS arena, the Japanese pharma has retooled its approach to clinical development.
As it prepares to compete in the KRAS arena, the Japanese pharma has retooled its approach to clinical development.